As recent studies suggest that low normal ALT value does not guarantee freedom from underlying NASH with advanced fibrosis [35-37], it remains to be solved whether FIB4 index can be useful for predicting advanced fibrosis in NAFLD subjects with normal ALT. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.